Arkolith/Insider Trading/AKTX/Form 4

Patel Samir Rashmikant

DirectorAkari Therapeutics Plc (AKTX) · full profile →Form 4 · filed Jan 7, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 3, 2025Grant(A)208K—$05.2B

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 3, 2025Grant(A)152.7M—$0152.7M

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-002864) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML